Specific Treatment Issues for Pregnant Women With HIV
- Keeping My Promise; Loving My Self (March 6, 2012)
From Black AIDS Institute
- Reyataz (Atazanavir) Label Revised, Adding Dosing Recommendations for Pregnancy and Postpartum Period (February 4, 2011)
From U.S. Food and Drug Administration
- Women With HIV Deserve Abortion Coverage: Tell the White House! (October 5, 2010)
From U.S. Positive Women's Network
- Taking HIV Meds Throughout Pregnancy Does More Good Than Harm, Study Suggests (September 15, 2008)
From aidsmap.com
- HIV Meds During Pregnancy Do Not Increase Birth Defect Risk, Major Study Finds (March 27, 2007)
- Six-Month Delay in Onset of Nevirapine-Based Antiretroviral Therapy Can Prevent Drug Resistance Following Single-Dose Nevirapine During Labor, Study Says (January 11, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Exposure to ARVs in Womb Does Not Affect Child's Mental Development, Canadians Report (October 31, 2006)
From aidsmap.com
- Nevirapine Resistance May Persist in Some Pregnant Women, Study Finds (May 3, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
On TheBodyPRO.com
- Efavirenz-Associated Neural Tube Defects Reported in Infants; Pregnancy Category Changed From C to D (March 31, 2005)
[Archived Article]
From U.S. Food and Drug Administration
- Crixivan (Indinavir) Label Revised -- Not Recommended for HIV-Infected Pregnant Patients (December 27, 2004)
From U.S. Food and Drug Administration
- Nelfinavir Levels a Third Lower in Pregnant Women (August 31, 2004)
[Archived Article]
However, the reduction doesn't appear to increase the baby's risk of contracting HIV, and in all but one case the pregnant women still had undetectable viral loads.
From aidsmap.com
- HIV Drug Classifications for Pregnant Women (May 25, 2004)
A brief review of which HIV medications have been studied for their safety in pregnant women.
To read PDF, click here.
From PositiveWords
- California: Program Helps Pregnant Mothers Infected With HIV (May 13, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Birth Defect in Baby Born to Efavirenz User (February 6, 2002)
[Archived Article]
From Canadian AIDS Treatment Information Exchange
On TheBodyPRO.com
- Cesarean Section Morbidity (Summer/Autumn 2001)
[Archived Article]
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- FDA Issues Warning About d4T and ddI During Pregnancy (January 22, 2001)
[Archived Article]
From Canadian AIDS Treatment Information Exchange
- FDA/Bristol Myers Squibb Issues Caution for HIV Combination Therapy With Zerit and Videx in Pregnant Women (January 5, 2001)
[Archived Article]
From U.S. Food and Drug Administration
- Important Drug Warning (January 5, 2001)
[Archived Article]
From U.S. Food and Drug Administration
- Preventing Mother-to-Child HIV Transmission (October 25, 2000)
[Archived Article]
Technical experts recommend use of antiretroviral regimens beyond pilot projects.
From UNAIDS
- Benefits of Resistance Testing During Pregnancy (December 1999)
[Archived Article]
In WISE Words, from Project Inform
- Fungal Infections During Pregnancy (September 1999)
[Archived Article]
In Project Inform Perspective, from Project Inform
- Elective Caesareans (April 1999)
[Archived Article]
In Body Positive, from Body Positive
- 98% Sure (October 1998)
[Archived Article]
Reducing transmission risk through cesarean section.
In AIDS Care, from San Francisco General Hospital
- Good for Both Mother and Child (October 1998)
[Archived Article]
The importance of good prenatal care for pregnant women with HIV.
In AIDS Care, from San Francisco General Hospital
- Efavirenz Pregnancy Warning (March 1998)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Cocktails During Pregnancy (February 1998)
[Archived Article]
In AIDS Care, from San Francisco General Hospital
- Highlights From the Conference on Global Strategies on the Prevention of Mother-to-Child HIV Transmission (January 1998)
[Archived Article]
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
|
Advertisement
|